Acorda Therapeutics Book Value:
391.64M for Dec. 31, 2012Acorda Therapeutics Historical Book Value Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 391.64M |
| Dec. 31, 2012 | 385.92M |
| Sept. 30, 2012 | 245.47M |
| June 30, 2012 | 229.65M |
| March 31, 2012 | 219.09M |
| Dec. 31, 2011 | 205.21M |
| Sept. 30, 2011 | 186.92M |
| June 30, 2011 | 162.75M |
| March 31, 2011 | 154.79M |
| Dec. 31, 2010 | 151.26M |
| Sept. 30, 2010 | 142.36M |
| June 30, 2010 | 122.70M |
| March 31, 2010 | 123.45M |
| Dec. 31, 2009 | 137.33M |
| Sept. 30, 2009 | 156.28M |
| June 30, 2009 | 171.80M |
| March 31, 2009 | 191.49M |
| Dec. 31, 2008 | 207.16M |
| Sept. 30, 2008 | 224.34M |
| June 30, 2008 | 112.41M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| Sept. 30, 2003 | Go Pro |
About Book Value of Equity
YCharts' book value of equity is the equivalent of total assets less total liabilities and preferred equity.
The book value of equity represents the equity of shareholders (from a balance sheet perspective) less the preferred stock.
Learn More
ACOR Book Value Benchmarks
| Companies | |
|---|---|
| Discovery Laboratories | 9.457M |
| Biogen Idec | 7.339B |
| Osiris Therapeutics | 33.82M |
ACOR Book Value Rankings
| Overall |
73rd percentile 2106 of 8002 |
| Sector |
80th percentile 136 of 684 in Healthcare |
| Industry |
91st percentile 20 of 248 in Biotechnology |
ACOR Book Value Range, Past 5 Years
| Minimum | 112.41M | Jun 2008 |
| Maximum | 391.64M | Mar 2013 |
| Average | 196.10M |
